福建瑞泰来医药科技

Fujian Ruitailai Pharmaceutical Technology is a specialized pharmaceutical company focused on the development and manufacturing of high-barrier complex formulations. The company maintains a strong emphasis on inhalation drug delivery systems, including dry powder inhalers (DPI), nasal sprays, and nebulized suspensions, as well as advanced ophthalmic preparations. Ruitailai operates as an integrated platform providing CRO and CDMO services to the global pharmaceutical industry, leveraging its expertise in micro-nano technology and device-drug combination products. Their portfolio targets significant therapeutic areas such as respiratory health and ophthalmology, aiming to provide high-quality alternatives to complex brand-name drugs. The company is headquartered in Fuzhou, China, and has established comprehensive R&D and GMP-compliant manufacturing facilities to support its internal pipeline and external partnerships.